1. Home
  2. KOPN vs MRVI Comparison

KOPN vs MRVI Comparison

Compare KOPN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kopin Corporation

KOPN

Kopin Corporation

N/A

Current Price

$2.15

Market Cap

424.9M

Sector

Technology

ML Signal

N/A

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$3.49

Market Cap

472.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KOPN
MRVI
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
424.9M
472.8M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
KOPN
MRVI
Price
$2.15
$3.49
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$4.25
$4.57
AVG Volume (30 Days)
1.9M
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
$1,044,337.00
$185,743,000.00
Revenue This Year
N/A
$11.80
Revenue Next Year
$41.25
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$1.67
52 Week High
$4.16
$4.11

Technical Indicators

Market Signals
Indicator
KOPN
MRVI
Relative Strength Index (RSI) 41.54 52.07
Support Level $1.67 $3.25
Resistance Level $2.31 $3.65
Average True Range (ATR) 0.14 0.19
MACD 0.01 0.04
Stochastic Oscillator 21.54 58.74

Price Performance

Historical Comparison
KOPN
MRVI

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: